XHKG2159
Market cap13mUSD
Dec 23, Last price
0.52HKD
1D
-1.89%
1Q
48.57%
IPO
-87.94%
Name
Mediwelcome Healthcare Management & Technology Inc
Chart & Performance
P/E
—
P/S
0.29
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-0.87%
Rev. gr., 5y
2.08%
Revenues
331m
+2.45%
Net income
-94m
L+0.38%
CFO
-76m
L+309.50%
Earnings
Jun 26, 2025
Profile
Mediwelcome Healthcare Management & Technology Inc., an investment holding company, provides integrated healthcare marketing solutions in the People's Republic of China. It offers medical conference, patient education and screening, and marketing strategy and consulting services; and contract research organization services consist of patient's recruitment and clinical data collection services. The company also operates a mobile application to provide internet hospital services comprising online follow up consultation to the physicians' existing patients and e-prescription services. It serves pharmaceutical companies, medical associations, and foundations. Mediwelcome Healthcare Management & Technology Inc. was founded in 2000 and is headquartered in Beijing, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 331,308 2.45% | 323,374 -54.35% | 708,358 63.86% | ||||
Cost of revenue | 407,447 | 416,997 | 718,203 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (76,139) | (93,623) | (9,845) | ||||
NOPBT Margin | |||||||
Operating Taxes | (287) | 2,708 | 386 | ||||
Tax Rate | |||||||
NOPAT | (75,852) | (96,331) | (10,231) | ||||
Net income | (94,096) 0.38% | (93,743) -2,118.15% | 4,645 -77.93% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 98,602 | ||||||
BB yield | -42.28% | ||||||
| Debt | |||||||
Debt current | 29,109 | 17,995 | 9,525 | ||||
Long-term debt | 11,646 | 25,878 | 40,837 | ||||
Deferred revenue | (405) | (287) | |||||
Other long-term liabilities | 405 | 287 | |||||
Net debt | (56,643) | (110,852) | (137,532) | ||||
| Cash flow | |||||||
Cash from operating activities | (75,582) | (18,457) | 262 | ||||
CAPEX | (1,401) | (4,296) | (24,992) | ||||
Cash from investing activities | 16,457 | (8,355) | (16,767) | ||||
Cash from financing activities | 906 | 54 | 92,844 | ||||
FCF | (104,642) | (41,722) | (43,550) | ||||
| Balance | |||||||
Cash | 80,352 | 154,021 | 174,829 | ||||
Long term investments | 17,046 | 704 | 13,065 | ||||
Excess cash | 80,833 | 138,556 | 152,476 | ||||
Stockholders' equity | 21,365 | 86,136 | 178,764 | ||||
Invested Capital | 129,733 | 135,725 | 160,087 | ||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | 191,442 | 185,817 | 182,218 | ||||
Price | 0.51 -63.04% | 1.38 7.81% | 1.28 | ||||
Market cap | 97,635 -61.92% | 256,427 9.94% | 233,239 | ||||
EV | 44,834 | 151,412 | 106,085 | ||||
EBITDA | (55,590) | (72,915) | 9,654 | ||||
EV/EBITDA | 10.99 | ||||||
Interest | 1,304 | 1,246 | 1,257 | ||||
Interest/NOPBT | |||||||